Update Training on CIWA and COWS

Slides:



Advertisements
Similar presentations
Alcohol: Research to Practice Gail D’Onofrio MD, MS Section of Emergency Medicine Yale University School of Medicine.
Advertisements

Best Practice Tom Shiffler, MD 7/23/10
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
A partner in service funded by the Mississauga Halton LHIN Community Concurrent Disorders Program (CCDP) Working Together Towards Recovery.
Utilizing the Adult Alcohol Withdrawal Syndrome Order form & CIWA-Ar tool Prepared by Buffalo General Hospital Departments of Pharmacy and Clinical.
Saving Lives By Strengthening Our Region’s Trauma Care System December 5, 2013 MANAGEMENT OF THE INJURED PATIENT IN ALCOHOL WITHDRAWAL.
Medication Assisted Treatment: An Introduction Deborah A. Orr, Ph.D., RN Remington College School of Nursing.
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum MODULE 6 Case Studies.
Joanna Piechniczek-Buczek, MD Boston University
Chapter 8: Chronic Alcohol Third leading preventable cause of death in the US.
7: Managing withdrawal Objectives
Keri Holmes-Maybank, MD Cathryn Caton, MD, MS MUSC June 21, 2012
A LCOHOL USE DISORDER. A LCOHOL USE IN I NDIA 21% of adult males use alcohol (Ray et al, 2004) 5% women use alcohol (Benegal et al, 2005) 50% of all drinkers.
CIWA Protocol: Fraser Health
Ken Saffier, MD, Natasha Pinto, MD And Patients CCRMC/HC Noon Conference February 18, 2010.
Restless Leg Syndrome By Judy Shives, MSN, NP, COHN-S.
Alcohol Withdrawal Resident Rounds July 10, 2007 Maggie Gordon, R2.
Delirium in the acute hospital
Opiate and Opioid Addiction
Vulnerability to Opioid Withdrawal Symptoms Among Chronic Low Back Pain Patients Subjects. In 2008, student research assistants consented and enrolled.
B ENZODIAZEPINE DEPENDENCE. WHO - ICD 10 C RITERIA FOR S UBSTANCE D EPENDENCE A definite diagnosis of dependence syndrome should usually be made only.
Delirium Patients Experiencing Delirium. Delirium Also known as an “acute state of confusion” It is considered a serious acute medical problem Indicates.
AddictionPresentedby Dr/ Said Said Elshama Dr/ Said Said Elshama.
 A patient presents to your small rural hospital emergency department at 7.30pm on a Saturday evening  He is sweating, c/o pain in his legs and back,
Alcohol Withdrawal Syndrome
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Intravenous fluids/non- pharmacologic pain interventions Lesson 20.
RISHP SHOWCASE 2015 C. MAXWELL M. KELLEY Minimizing Polypharmacy: Addressing Therapeutic Duplications.
Dehydration & Frostbite
By Katelyn Battochio. Morphine Morphine is a naturally occurring substance of the juice in the unripe seedpods of the opium poppy. A potent narcotic analgesic,
Clinical Management Course: Medical Complications of Alcoholism Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology.
Chapter 27 Central Nervous System Sedatives and Hypnotics.
Liaison and Emergency Psychiatry Moray 1 Alcohol dependence and Safe Withdrawal In-patient detox in Dr Grays.
March 2016 ALCOHOL WITHDRAWAL.  Recognition of alcohol withdrawal symptoms  Ensuring appropriate treatment so that complications are prevented  Describing.
Samantha Allen PharmD Candidate 2012 Case Presentation April 19, 2012 Alcohol Withdrawal Management.
SUBSTANCE ABUSE Substance: any drug, medication, or toxin that shares potential for abuse Addiction: physiologic/psychologic dependence causing withdrawal.
Parenteral Vitamin Repletion in Alcohol Use Disorder Vicki P. Cheng, Cory Taylor UCI Internal Medicine Residency Cost-Conscious Medicine Series.
Common Presentations Depression With or without suicidality Adjustment reactions Mania Psychosis Intoxication Withdrawal.
INTRODUCTION Acute alcohol withdrawal syndrome occurs when individuals with alcohol dependency abruptly stop or substantially reduce their alcohol consumption.
Managing Alcohol and Opioid Withdrawals
Sedation during mechanical ventilation : A trial of benzodiazepine and opiate in combination Crit Care Med 2006 Vol. 34, No. 5 R2 이윤정 Paul S. Richman,
Substance Abuse Chapter 11. Substance Abuse  Self-administration of a drug in a manner that does not conform to the norms within the patient’s own culture.
 Discuss the symptoms and signs of alcohol withdrawal.  Discuss the management of alcohol withdrawal.
Addressing the issue: Prescription Drug Misuse in North Carolina
Dementia Care Managing pain and symptom control
ALCOHOLISM Alcoholism is a chronic disease characterized
Managing Alcohol and Opioid Withdrawals
Clinical Opiate Withdrawal – Symptom Management Protocol
Substance-Related AND Addictive Disorders/Drug Abuse
Across the Continuum….. Managing the Inpatient
Following this training the nurse will be able to:
Acute Pain Management Solomon Liao, M.D.
Alcohol Withdrawal in Acute Care
NERVE AGENT EXPOSURE CA128.
Across the Continuum….. Managing the Inpatient
UCI internal medicine mini-lecture series By Julia Kao
Rohypnol Bellik Bolkeim Period.1.
Presented by J. Arzaga, MSN, RN
Treating Alcohol Withdrawal
Information for Workers
Treating Opioid Withdrawal with Buprenorphine/Naloxone
Clinical tips and pearls
Antidepressant Discontinuation Syndrome
High-Yield Terms to Learn Abstinence syndrome  A term used to describe the signs and symptoms that occur on withdrawal.
Treating Opioid Withdrawal with Buprenorphine/Naloxone
Medication Assisted Treatment of Opioid Use Disorder
For PAWWS (> or = 4) or CIWA (> or = 9)
Bassett-UMass MAT ECHO.
Question 11 – Methadone overdose
Acute Pain Management & Addiction
Presentation transcript:

Update Training on CIWA and COWS 1. scoring:

Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar) ©2008 Rush University Medical Center

Alcohol Withdrawal 101 SYMPTOMS TIME OF APPEARANCE AFTER CESSATION OF ALCOHOL USE Minor withdrawal symptoms: insomnia, tremulousness, mild anxiety, gastrointestinal upset, headache, diaphoresis, palpitations, anorexia 6 to 12 hours Alcoholic hallucinosis: visual, auditory, or tactile hallucinations 12 to 24 hours* Withdrawal seizures: generalized tonic-clonic seizures 24 to 48 hours† Alcohol withdrawal delirium (delirium tremens): hallucinations (predominately visual), disorientation, tachycardia, hypertension, low-grade fever, agitation, diaphoresis *— Symptoms generally resolve within 48 hours. †— Symptoms reported as early as two hours after cessation. ‡— Symptoms peak at five days. Delirium tremens has a 1-5% mortality rate. Table. Bayard, Mcintyre, Hill & Woodside, 2004. 48 to 72 hours‡ ©2008 Rush University Medical Center Symptoms of Alcohol Withdrawal Syndrome *— Symptoms generally resolve within 48 hours. †— Symptoms reported as early as two hours after cessation. ‡— Symptoms peak at five days.

Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar): 10 items/5 minutes Assessing for tremor: Observe patient with extended arms and fingers spread Put the patient’s hands on your own to feel the tremor Provide a cup of water to observe the tremor Mild tremor (1-2): fine, flutter like movements Moderate tremor (3-4): brings cup to mouth with 1 hand, but noticeable tremor Severe tremor (5-6): requires 2 hands to bring cup to mouth Full body tremor (7): patient can’t stand unassisted and has tremors all over, including the tongue Assessing for paroxysmal sweats Rub the patient’s palms, back of the neck and forehead Mild sweat (1-2): detect moisture Moderate sweat (3-4): detect sweat on the forehead and palms- clothing is damp Severe sweat (6-7): clothing and bedding are wet, patient is wet and clammy Drenching (7): clothing and bedding are soaked ©2008 Rush University Medical Center

Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar) Assessing Agitation Subjective: patient describing feeling unable to keep still Objective: observed restlessness, tossing and turning, pacing Assessing for Tactile disturbance Initially described as itching Progresses to numbness and tingling Severe symptoms: feeling things crawling on skin Assessing for Visual hallucinations Mild to moderate: increased sensitivity to light Severe: responding to visual hallucinations (including seeing shadows) Assessing for Auditory hallucinations Mild to moderate: increased sensitivity to noise Severe: auditory hallucinations ©2008 Rush University Medical Center

Medications for CIWA-Ar Protocol at Rush Diazepam (VALIUM) available both PO and IV has a fast onset and long is long acting use with caution in patients with severe liver disease 5 mg of diazepam = 1 mg of lorazepam Lorazepam (ATIVAN) intermediate acting recommended for use in patients with severe liver disease Thiamine, multi vitamin and folic acid Given PO unless patient is NPO or signs of Wernicke’s Wernicke’s encephalopathy: Caused by deficiency in vitamin B1 (thiamine) S/S: Opthalmophlegia, Ataxia, Confusion If untreated, deficits may become permanent ©2008 Rush University Medical Center

Changes to CIWA-Ar Protocol at Rush Assessment occurs around the clock; wake patient if sleeping! CIWA-Ar assessment every 4 hrs unless: Score < 8 on 3 consecutive assessments = assess every 8 hrs Score is 8-15 or higher = reassess in 2 hrs & medicate as below Score >15 on 3 consecutive assessments = alert primary service CONSIDER ICU when CIWA remains >15 AFTER 3rd consecutive dose of diazepam (20mg) or lorazepam (4mg) ICU ONLY: Use RASS scoring with target +1 to -1 if patient unable to participate in CIWA scoring CIWA SCORE SEVERITY LORAZEPAM DIAZEPAM FREQUENCY 8-15 MODERATE 2 mg PO/IV 10 mg PO Q2 hrs PRN >15 SEVERE 4 mg PO/IV 20 mg PO ©2008 Rush University Medical Center

Question A patient is admitted to GMF for management of alcohol withdrawal. At 0200, he/she has a CIWA score of 16 and diazepam (VALIUM) 20 mg PO is administered. At 0400, CIWA score is 18 and diazepam (VALIUM) 20 mg PO is administered. At 0600, CIWA score is 22. What is the appropriate next action? Call primary service immediately and request transfer to ICU Give lorazepam 4 mg because diazepam does not appear to be working Give diazepam (VALIUM) 20 mg PO and then alert primary service that 3 consecutive CIWA scores have been > 15 Give diazepam (VALIUM) 20 mg PO and reassess in 2 hours ©2008 Rush University Medical Center

Clinical Opioid Withdrawal Scale (COWS) ©2008 Rush University Medical Center

Opioid Withdrawal 101 Onset of symptoms: Heroin: begins within hours of last use & diminish by day 4 Methadone: begins within days and diminish by day 10 Prescription opioids: varies based on ½ life of opioid ©2008 Rush University Medical Center

Clinical Opioid Withdrawal Scale COWS Previously referred to as the “CIWA Opioids Scale” 2- 10 minute to complete including observation and scoring ©2008 Rush University Medical Center

Clinical Opioid Withdrawal Scale Items to assess: Resting Pulse Rate Recorded after the patient has been sitting or lying for 1 minute. Sweating Over the past ½ hour Observation and patient report Restlessness If sitting still without obvious restlessness, ask “are you having difficulty sitting still?” Range from subjective report to clear observation of frequent movement Pupil size Observed in room light Turn on the lights in the room for assessment and allow for adjustment Bone or joint aches Make a baseline assessment of pain (i.e does the patient have any chronic pain issues) The assessment is based only on additional pain, outside of their baseline ©2008 Rush University Medical Center

Clinical Opioid Withdrawal Scale Items to assess: Runny nose or tearing Range in severity from patient report to observation Often observed “sniffling” GI upset Over the last 30 minutes Ask patients to show staff when they have episodes of diarrhea or vomiting Tremor Put patient hands on top of yours to be able to feel a fine tremor Yawning Scored based on the frequency of yawning during observation Anxiety or Irritability Combination of self-report and observation Gooseflesh skin Ask patient to hold out arm, run fingers on arm to feel piloerection ©2008 Rush University Medical Center

Medications Available for Management of Opioid Withdrawal Buprenorphine-naloxone (SUBOXONE) available to all patients experiencing opioid withdrawal dosing as follows: COWS score 8-12 give 1 tablet (2-0.5 mg) COWS score 13 or more give 2 tablets (2-0.5 mg) When buprenorphine is given: reassess COWS scale in 2 hours re-dose as indicated not to exceed 8 mg in 12 hours Hold for excessive sedation or POSS of 3 or more ©2008 Rush University Medical Center

Changes to Opioid Withdrawal Protocol Use the same flowsheet; no assessment changes Referred to only as COWS Administered around the clock, not “only when awake” After buprenorphine-naloxone (SUBOXONE) is given, reassess COWS in 2 hours and give additional medication as indicated. Lorazepam not indicated in opioid withdrawal ©2008 Rush University Medical Center

Question Patient is evaluated and has a COWS score of 10: 2 points for anxiety or irritability, 2 points for bone or joint aches and 2 points for runny nose or tearing and 2 points for GI distress. What is the appropriate intervention? Re-evaluate in 4 hours Administer buprenorphine-naloxone (SUBOXONE) 2-0.5 mg and reassess in 2 hours Offer hydroxyzine (VISTARIL/ATARAX) 25 mg and ibuprofen 600 mg Request 1 time dose of lorazepam (ATIVAN) ©2008 Rush University Medical Center

References Bayard, M., Mcintyre, J., Hill, K.R., & Woodside, J. Jr. (2004). Alcohol withdrawal syndrome. Am Fam Physician, 69(3), 1443-1450. Center for Substance Abuse Treatment. Detoxification and Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series, No. 45. HHS Publication No. (SMA) 15-4131. Rockville, MD: Center for Substance Abuse Treatment, 2006 Hurst, G.B. (2012). Caring for patients in alcohol withdrawal.) American Nurse Today, 7(6). Retrieved from https://www.americannursetoday.com/caring-for-patients-in-alcohol-withdrawal/ Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. (1989). Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for alcohol scale (CIWA-Ar). Br J Addict, 84(11),1353-1357. Wesson D.R. & Ling, W. (2003). The Clinical Opiate Withdrawal Scale [COWS]. J Psychoactive Drugs, 35(2), 253-259. Add scoring ©2008 Rush University Medical Center